In melanoma, upregulation of matrix metalloproteinases (MMPs) is associated with migration of the tumor, and upon treatment of B16F10 cells with NPC-402, it dose-dependently downregulates the expression of MMP1 and MMP9 compared to untreated (Figures 5F, G). Here, MMP9 is linked to neoplasm.